The medication was designed to help lower LDL-C levels with just two doses per year.
The report, primarily focused on compensation data in the United States, also examined how COVID-19 continues to impact the country's workforce.
Peter A. McCullough, MD, has been no stranger to controversy during the ongoing pandemic.
Johnson & Johnson’s vaccine has been associated with an elevated risk of thrombosis with thrombocytopenia syndrome.
The new analysis, published in JACC: Heart Failure, included data from 75 different studies.
The new analysis focused on nearly 5 million individuals who received either the Moderna or Pfizer/BioNTech vaccine.
We need to make the future instead of waiting for it to happen.
The system was designed to treat both pediatric and adult patients.
The Philips CavaClear Laser Sheath earned the agency’s breakthrough device designation back in July.
Innovate Healthcare thanks our partners for supporting our newsletters.Sponsorship has no influence on editorial content.Interested in reaching our audiences, contact our team*|LIST:ADDRESSLINE|*You received this email because you signed up for newsletters from Innovate Healthcare.Change your preferences or unsubscribe hereContact Us | Unsubscribe from all | Privacy Policy© Innovate Healthcare, a TriMed Media brand
